Validation of pharmacy records in drug exposure assessment

Journal of Clinical Epidemiology

Volumn 50, Issue 5, 1997, Pages 619-625

  Lau, Hong S ^a   De Boer, Anthonius ^a   Beuning, Karin S ^a   Porsius, Arijan ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Drug exposure; Home interview; Pharmacoepidemiology; Pharmacy records; Validation

Indexed keywords

AGED; ARTICLE; COMMUNITY; DRUG EXPOSURE; FEMALE; HOME; HUMAN; INFORMATION SYSTEM; INTERVIEW; MALE; NORMAL HUMAN; PATIENT COMPLIANCE; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL; RELIABILITY;

AGED; AGED, 80 AND OVER; COMMUNITY PHARMACY SERVICES; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; FAMILY PRACTICE; FEMALE; HUMANS; MALE; MEDICAL RECORDS; PATIENT COMPLIANCE; PRESCRIPTIONS, DRUG; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 0031010532     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(97)00040-1     Document Type: Article

References (26)

1. Rothman KJ. Modern Epidemiology. Boston: Little, Brown and Company; 1986.
2. Carson JL, Strom BL. Medicaid databases. In: Strom B, Ed. Pharmacoepidemiology. 2nd ed. Chichester: John Wiley & Sons; 1994: pp. 199-216.
3. Friedman GD. Kaiser Permanente Medical Care Program: Northern California and Other Regions. In: Strom B, Ed. Pharmacoepidemiology. 2nd ed. Chichester: John Wiley & Sons; 1994: pp. 187-198.
4. Strand LM, Downey W. Health databases in Saskatchewan. In: Strom B, Ed. Pharmacoepidemiology. 2nd ed. Chichester: John Wiley & Sons; 1994: pp. 217-230.
5. Herings RMC. PHARMO; a record linkage system for post-marketing surveillance of prescription drugs in the Netherlands [Dissertation]. Utrecht University; 1993.
6. Paganini-Hill A, Ross RK. Reliability of recall of drug usage and other health-related information. Am J Epidemiol 1982; 116: 114-122.
7. Lessler BL, Harris BSH. Medicaid Data as a Source for Post-marketing Surveillance Information. Final Report. Research Triangle Park, NC: Research Triangle Institute; 1984.
8. Tamblyn R, Lavoie G, Petrella L, Monette J. The use of prescription claims databases in pharmacoepidemiological research: The accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epidemiol 1995; 48: 999-1009.
9. Stergachis AS. Evaluating the quality of linked automated databases for use in pharmacoepidemiology. In: Hartzema AG, Porta MS, Tilson HH, Eds. Pharmacoepidemiology: An Introduction. 2nd ed. Cincinnati: Harvey Whitney Books Company; 1991: pp. 222-234.
10. Heerdink ER, Leufkens HG, Koppedraaijer C, Bakker A. Information on drug use in the elderly: A comparison of pharmacy, general practitioner and patient data. Pharm Weekbl [Sci] 1995; 17: 20-24.
11. Johnson RE, Vollmer WM. Comparing sources of drug data about the elderly. J Am Geriatr Soc 1991; 39: 1079-1084.
12. van Staa TP, Abenhaim L, Leufkens H. A study of the effects of exposure misclassification due to the time-window design in pharmacoepidemiologic studies. J Clin Epidemiol 1994; 47: 183-189.
13. West SL, Strom BL, Freundlich B, Normand E, Koch G, Savitz DA, et al. Completeness of prescription recording in outpatient medical records from a health maintenance organization. J Clin Epidemiol 1994; 47: 165-171.
14. Strom BL, Carson JL; Halpern AC. Using a claims database to investigate drug-induced Stevens-Johnson syndrome. Stat Med 1991; 10: 565-576.
15. Guess HA, West R, Strand LM, et al. Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of nonsteroidal anti-inflammatory drugs in Saskatchewan. J Clin Epidemiol 1988; 41: 35-45.
16. Christensen DB, Williams B, Goldberg HI, Martin DP, Engelberg R, LoGerfo JP. Comparison of prescription and medical records in reflecting patient antihypertensive drug therapy. Ann Pharmacother 1994; 28: 99-104.
17. Shapiro S. The role of automated record linkage in the post-marketing surveillance of drug safety: A critique. Clin Pharmacol Ther 1989; 46: 371-386.
18. Leufkens HGM. Pharmacy Records in Pharmacoepidemiology: Studies on Antiinflammatory and Antirheumatic Drugs [Dissertation]. Utrecht University; 1990.
19. WHO. Guidelines for ATC Classification. Oslo: WHO Collaborating Centre for Drug Statistics Methodology - Nordic Council on Medicines; 1990.
20. Herings RMC, Deboer A, Stricker BHC, Leufkens HGM, Porsius A. Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme. Lancet 1995; 345: 1195-1198.
21. Visser LE, Stricker BHC, Vandervelden J, Paes AHP, Bakker A. Angiotensin converting enzyme inhibitor associated cough: A population-based case-control study. J Clin Epidemiol 1995; 48: 851-857.
22. Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton LJ. Psychotropic drug use and the risk of hip fracture. N Engl J Med 1987; 316: 363-369.
23. Carson JL, Strom BL, Duff A, et al. Acute liver disease associated with erythromycins, sulfonamides, and tetracyclines. Ann Int Med 1993; 119: 576-583.
24. Spriet A, Beiler D, Dechorgnat J, Simon P. Adherence of elderly patients to treatment with pentoxifylline. Clin Pharmacol Ther 1980; 27: 1-8.
25. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Quellette VL. How often is medication taken as prescribed? A novel assessment technique. JAMA 1989; 261: 3273-3277.
26. Pullar T, Birtwell AJ, Wiles PG, Hay A, Feely MP. Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily. Clin Pharmacol Ther 1988; 44: 540-545.